You can get a bit more agility by swapping one of the Werewolves and a Zombie for the second Ghoul and Wraith. Starting with the Flesh Golems gives them the most time to gather star player points but the trade off is only two team rerolls. Going to one Wraith and one Ghoul nearly gives you an entire Regeneration option and that extra player who is better at ball handling. It would have also meant that you would have only had the two Werewolves for doing the ball handling. Under the new rules you’re 10k over the amount of starting money so can no longer do that. You used to be able to go with no Ghouls and get all the positional players with Regeneration into a starting lineup. 10x Regeneration Necromantic Horror Quantity You would like the Flesh Golems early on as they can be slow to skill up, however they are pretty useful even as rookie players when you eventually get them. Whilst you have to forgo the Flesh Golems you can start saving for them straight away as you’re not allowed to have an Apothecary anyway. Starting with three of the expensive rerolls avoids having to save up an extortionate amount later on.
It also maximises the initial Block, Dodge and the Wraiths and Werewolves both have some other handy skills. (The old version had 30k left in the bank.) The team starts with all six of it’s more agile and faster players (even if the Wraiths can’t handle the ball). When pricing out this build I was surprised to see that you can still fit in three rerolls given the price rises on the players. Maximum Agility Necromantic Horror Quantity QTYīlock, Foul Appearance, No Hands, Regeneration, Side Step This is going to have quite an impact on the starting rosters coaches may have been used to. Speaking of price increases the same has also happened to the Ghouls, Werewolves and Flesh Golems. They’ve lost the Wights and have been replaced by non ball handling Wraiths who are also slightly more expensive. Necromantic Horror teams look a little bit different from previous editions. Necromantic Horror Starting Rosters Overview
0 kommentar(er)
